🇺🇸 FDA

Intelligence · Clinical Pipeline

Regeneron UK Pipeline

All ClinicalTrials.gov programs at Regeneron UK — phase, modality, and trial IDs.

Programs
176

Quick answer

Regeneron UK has 176 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. SNS-101 (anti-VISTA)

    Regeneron UK Limited

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  2. Sarilumab

    Regeneron UK Limited

    Morphea, Plaque Form

    phase 2 small molecule terminated

    1 trial

  3. Sarilumab

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule completed

    1 trial

  4. Sarilumab

    Regeneron UK Limited

    Ankylosing Spondylitis

    phase 2 small molecule terminated

    2 trials

  5. Sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule active

    1 trial

  6. Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept

    Regeneron UK Limited

    Thyroid Eye Disease

    phase 2 small molecule completed

    1 trial

  7. Tirzepatide

    Regeneron UK Limited

    Obesity

    phase 2 small molecule completed

    1 trial

  8. Trevogrumab-Part A

    Regeneron UK Limited

    Obesity

    phase 2 small molecule active

    1 trial

  9. Ubamatamab

    Regeneron UK Limited

    Advanced/Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  10. Ubamatamab

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  11. Ubamatamab

    Regeneron UK Limited

    Recurrent Ovarian Cancer

    phase 2 small molecule active

    1 trial

  12. Ubamatamab

    Regeneron UK Limited

    SMARCB1-Deficient Malignancies

    phase 2 small molecule active

    1 trial

  13. VEGF Trap Eye

    Regeneron UK Limited

    Macular Degeneration

    phase 2 small molecule completed

    1 trial

  14. VV1

    Regeneron UK Limited

    Melanoma

    phase 2 mab active

    1 trial

  15. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

  16. ZIV-Aflibercept

    Regeneron UK Limited

    Metastatic Uveal Melanoma

    phase 2 small molecule active

    1 trial

  17. Ziv-Aflibercept

    Regeneron UK Limited

    Uveal Melanoma

    phase 2 mab terminated

    1 trial

  18. aflibercept

    Regeneron UK Limited

    Neovascular (Wet) Age-Related Macular Degeneration

    phase 2 small molecule completed

    1 trial

  19. aflibercept + FOLFIRI

    Regeneron UK Limited

    Metastatic Colorectal Cancer

    phase 2 small molecule terminated

    1 trial

  20. aflibercept injection (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Macular Degeneration

    phase 2 mab completed

    1 trial

  21. casirivimab+imdevimab

    Regeneron UK Limited

    COVID-19

    phase 2 small molecule terminated

    2 trials

  22. casirivimab+imdevimab

    Regeneron UK Limited

    Healthy

    phase 2 small molecule completed

    2 trials

  23. cemiplimab

    Regeneron UK Limited

    Melanoma

    phase 2 small molecule active

    1 trial

  24. cemiplimab

    Regeneron UK Limited

    Advanced Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  25. cemiplimab

    Regeneron UK Limited

    Carcinoma, Basal Cell

    phase 2 small molecule completed

    1 trial

  26. cemiplimab

    Regeneron UK Limited

    Cutaneous Basal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  27. cemiplimab (monotherapy)

    Regeneron UK Limited

    Relapsed Solid Tumor

    phase 2 small molecule terminated

    1 trial

  28. dupilumab

    Regeneron UK Limited

    Allergic Bronchopulmonary Aspergillosis

    phase 2 small molecule completed

    1 trial

  29. dupilumab

    Regeneron UK Limited

    Chronic Sinusitis

    phase 2 mab completed

    1 trial

  30. evinacumab

    Regeneron UK Limited

    Hypertriglyceridemia

    phase 2 small molecule terminated

    1 trial

  31. evinacumab

    Regeneron UK Limited

    Severe Hypertriglyceridemia (sHTG)

    phase 2 small molecule completed

    1 trial

  32. vidutolimod

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Regeneron UK have?

176 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.